Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Earnings release
confidence 95%
filed 2026-10-22
Item 2.02
The filing discloses J. W. Mays, Inc.'s financial results for the three and twelve months ended July 31, 2026, including revenues and net loss figures with year-over-year comparisons, reported via a press release dated October 21, 2026 attached as Exhibit 99(i). This is a standard earnings release disclosure under Item 2.02.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 92%
filed 2026-10-22
EX-99.1
The press release announces that Yimutian has regained compliance with Nasdaq's minimum stockholders' equity requirement of US$2.5 million after previously being out of compliance. While framed positively as a "compliance letter," the disclosure reveals the Company was subject to a delisting threat, is now under mandatory panel monitoring for one year, and faces automatic delisting without cure rights if it falls out of compliance again during that period. This is material to investors as it reflects prior listing jeopardy and ongoing heightened delisting risk under Nasdaq Listing Rule 5815(d)(4)(B).
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-10-22
EX-99.1
This press release announces a material acquisition of European Lithium Limited by Critical Metals Corp. The disclosure specifies the transaction structure (Court-approved schemes of arrangement), the consideration mechanism (issuance of 0.045 new Critical Metals Corp shares per European Lithium share, subject to a floor and ceiling price), and the imminent shareholder vote scheduled for October 22, 2026. This constitutes entry into a material acquisition transaction requiring disclosure under Item 1.01 or 2.01 of Form 8-K equivalents.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-10-22
EX-99.1
The exhibit discloses the launch of a tender offer by Inversiones ASPI S.A. (subsidiary of Holcim Ltd.) to acquire up to 211,882,902 shares representing approximately 49.99% of Cementos Pacasmayo's common shares at S/ 8.93 per share. This constitutes a material acquisition activity under Items 1.01/2.01, with simultaneous offers in Peru and the United States commencing October 22, 2026 and expiring November 20, 2026. The acquisition of nearly 50% of the company's equity is clearly material to a reasonable investor's assessment of the registrant.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-10-22
EX-99.1
This exhibit discloses a regulatory challenge to the valuation report underlying a tender offer (OPA) by Holcim Ltd. for Cementos Pacasmayo's common shares. The SMV's Official Letter No. 5332-2026-SMV/11.1 raises material observations regarding the minimum price determination, which is central to the M&A transaction. The regulator's detailed objections to the valuation methodology and assumptions directly threaten the transaction's pricing and execution, making this a material disclosure of M&A activity in progress.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-10-22
The 6-K discloses poll results from three shareholder meetings held on October 21, 2026: an Extraordinary General Meeting and separate Class A and Class B shareholder meetings. All three resolutions passed at all three meetings, including: (1) variation of Class B Share voting rights from 20 to 100 votes per share and elimination of dividend/liquidation rights; (2) adoption of amended memorandum and articles of association; and (3) issuance of 7,000,000 Class B Shares to Grande Holding Limited. These are material governance and capital structure changes requiring shareholder approval.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-10-22
EX-99.4
This exhibit discloses unaudited pro forma financial information for Critical Metals Corp.'s acquisition of European Lithium Ltd. under a Scheme Implementation Deed entered into on May 18, 2026, with completion expected in November 2026. The exhibit details the material acquisition transaction, including amendments to the SID (July 3 and August 19, 2026), accounting treatment under IFRS, and pro forma combined balance sheet and statement of operations as of June 30, 2026. This is a clear material acquisition activity requiring disclosure under Item 1.01 or equivalent 6-K exhibit standards.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-10-22
EX-99.1
The press release announces that Linkage Global has regained compliance with Nasdaq's minimum bid price requirement (Nasdaq Listing Rule 5550(a)(2)) after previously falling out of compliance on June 3, 2026. The Company was required to maintain a closing bid price of at least $1.00 per share for 10 consecutive business days to cure the deficiency; it achieved 20 consecutive business days at or above that threshold from September 21 through October 16, 2026, and Nasdaq has now closed the matter. This is a material delisting-risk disclosure because it directly addresses a continued listing qualification issue that, if unresolved, would have resulted in delisting from the Nasdaq Capital Market.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 75%
filed 2026-10-22
EX-99.1
The press release announces a voluntary pause of an at-the-market (ATM) equity offering program. While the pause itself is a suspension rather than an issuance, it relates directly to a dilutive equity offering mechanism. The disclosure is material because it signals the Company's capital-raising strategy and market positioning; however, the pause (rather than an active sale or new issuance) creates some ambiguity about whether this is best classified as a dilutive_issuance event or a strategic operational decision. The ATM program remains in place and could resume, making this a material capital-structure disclosure.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 92%
filed 2026-10-22
EX-99.1
The press release announces a 1-for-100 share consolidation explicitly undertaken "to enable the Company to regain compliance with Nasdaq Marketplace Rule 5550(a)(2) and maintain its listing on the Nasdaq Capital Market." This disclosure directly addresses a failure to satisfy a continued listing rule and the remedial action taken to avoid delisting, which is material to investors assessing the registrant's exchange listing status.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-10-22
EX-99.1
Alpha Tau announced the signing of a Memorandum of Understanding (MOU) with Samsung Medical Center to explore a potential clinical trial of Alpha DaRT for pancreatic cancer patients in South Korea. This represents a material operational and strategic milestone—the company's first clinical trial in Korea and expansion of its pancreatic cancer program to a sixth country. While not a discrete M&A transaction, the MOU signals meaningful progress in the company's clinical development and geographic expansion strategy, which would affect a reasonable investor's assessment of the registrant's pipeline and market opportunities.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 92%
filed 2026-10-22
This exhibit is an extract from the minutes of BrasilAgro's Annual and Extraordinary General Shareholders' Meeting held on October 21, 2026. It discloses the results of shareholder votes on multiple resolutions, including approval of financial statements for fiscal year ended June 30, 2026, dividend distribution of R$30 million, Fiscal Council elections, and critically, approval of a merger of Agrifirma Agro Ltda. into BrasilAgro effective October 31, 2026. The merger approval (Item B(iv)) with 60,104,903 votes in favor represents a material acquisition/change of control event, and the dividend distribution of R$30 million is material. The disclosure of shareholder vote results on these matters is the primary content of this filing.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-10-22
EX-99.1
This press release announces a strategic collaboration agreement between Wearable Devices and Encord to combine neural-sensing wearable data with Physical AI data infrastructure. The agreement establishes a commercial framework for device sales and usage-based compensation, representing a material operational and commercial partnership that expands the company's addressable market into Physical AI and robotics applications. While not a discrete M&A transaction, the collaboration creates new revenue streams and strategic positioning that would affect a reasonable investor's assessment of the company's growth prospects.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-10-22
Item 8.01
K&F Growth Acquisition Corp. II and David's Bridal announced entry into an amended letter of intent for a proposed business combination whereby Pearl (David's Bridal's wedding planning division) would become a standalone public company via merger with K&F, valued at approximately $350 million enterprise value with a $75 million PIPE financing.
View raw filing on EDGAR →
6-K
Governance Other
confidence 72%
filed 2026-10-22
EX-99.1
This is a CEO letter to shareholders announcing the completion of WISeQey's redomiciliation and Nasdaq listing (effective October 5, 2026), alongside the subsidiary WISeSat.Space's successful business combination and Nasdaq listing (October 2, 2026). While the letter articulates strategic vision and priorities, the core disclosed events are corporate restructuring milestones—the cross-border merger, redomiciliation, and dual Nasdaq/SIX listings—which are governance and capital-structure matters. The letter does not announce discrete financial results, M&A activity (the transactions are already completed), or operational events; it is primarily a strategic communication following completed corporate transactions. This is material to shareholders as it establishes the new corporate foundation and ownership structure (WISeQey holding ~88.5% of WISeSat.Space), but the event type is governance-related rather than a specific named category.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-10-22
The 8-K discloses preliminary unaudited financial results for Q3 2026 under Item 2.02 (Results of Operations and Financial Condition), with a press release attached as Exhibit 99.1 announcing third-quarter revenue of $35.3 million. This is a standard earnings release disclosure, though preliminary and subject to completion of financial closing procedures.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-10-22
The 6-K discloses a Nasdaq Hearings Panel decision on October 7, 2026, denying MaxsMaking's request to reinstate trading and ordering delisting of the Company's securities. The Panel cited trading activity indicative of potential manipulation, insufficient liquidity, and inadequate public float. Trading has been halted since December 2, 2025, and the Company's only remaining recourse is a request for review by the Listing and Hearing Review Council, which does not stay the suspension. This is a material delisting event under Item 3.01 equivalent.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-10-22
Item 1.02
The filing discloses termination of a material marketing and sub-advisory services agreement between the Sponsor (21Shares US LLC) and ARK Investment Management LLC, effective December 22, 2026. This is a material operational event affecting the Trust's service provider relationships and brand identity, evidenced by the planned name change from "ARK 21Shares Bitcoin ETF" to "21Shares Bitcoin ETF" and ticker symbol change from ARKB to TBIT. While Item 1.02 typically covers M&A terminations, this disclosure centers on the termination of an ongoing service agreement rather than a material acquisition or disposition, making it an operational matter affecting the Trust's business continuity and marketing support.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-10-22
Item 5.02
The filing discloses the appointment of Kenneth J. Anderson to the Board of Directors as a Class III director effective October 17, 2026, filling a vacancy created by Kanat Mynzhanov's resignation on October 16, 2026. While both a departure and appointment occur, the principal disclosed action centers on the appointment of a new director with detailed background information and committee assignments (Audit Committee and Compensation Committee). This is a material governance event affecting board composition.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 92%
filed 2026-10-22
The filing's primary disclosure is Item 5.07, which reports the results of an Extraordinary General Meeting held on October 19, 2026. Shareholders voted on three proposals: (1) approval of an amendment to extend the business combination deadline from October 25, 2026 to October 25, 2027 (approved 7,721,514 for, 199,595 against); (2) approval of a trust agreement amendment to allow monthly extensions with sponsor funding (approved with identical vote counts); and (3) an adjournment proposal (rendered moot). The filing also discloses that 5,725,962 public shares were redeemed at approximately $11.03 per share. This is a material shareholder vote on a SPAC extension, directly affecting the company's timeline and capital structure.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-10-22
EX-99.1
Collective Mining disclosed an updated mineral resource estimate for the Apollo deposit at its Guayabales Project in Colombia, effective October 13, 2026, presenting detailed geological, exploration, and resource estimation data with tabulated mineral resources and recommendations for further work.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-10-22
Item 1.01
The Company issued a Series B warrant to purchase 125,000 shares of Common Stock as consideration for waiving restrictions on its at-the-market offering. This is a dilutive equity issuance to an institutional investor under Section 4(a)(2) exemption. While the primary transaction is a waiver agreement, the material economic substance is the issuance of equity securities (warrants) that will dilute existing shareholders upon exercise, which is characteristic of dilutive_issuance events.
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-10-22
Item 2.01
XCF Global completed an all-stock business combination with Southern Energy Renewables Inc. and DevvStream Corp. on October 16, 2026, with Southern and DevvStream becoming wholly owned subsidiaries. The transaction creates a vertically integrated alternative energy platform with 2027 guidance of $650-700M gross product sales, $120-130M net revenue, and $70-75M EBITDA, and combined 2030 targets of $1.4B+ gross product sales and $300M+ EBITDA.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-10-22
Item 5.02
XCF Global appointed Christopher Cooper as Chairman of the Board, Wray Thorn as President and Chief Financial Officer, and three new directors (Chad J. Langley, John Wharton, and Carl Stanton) effective upon or shortly after the business combination closing. The appointments include employment agreements with base salary, bonuses, and equity grants.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-10-22
EX-99.1
This press release announces a 1-for-16 reverse share split effective October 27, 2026, reducing outstanding shares from approximately 24.5 million to 1.5 million and adjusting authorized shares, par value, and warrant/option exercise prices accordingly. While a reverse split is a governance/capital structure event rather than a discrete material event like M&A or restatement, it is material to investors as it affects share count, trading mechanics, and potential delisting-risk implications (reverse splits often signal financial distress or compliance pressure). The disclosure is clearly governance-related but does not fit the specific named categories (exec appointment/departure, compensation, shareholder vote results, etc.), making `governance_other` the appropriate classification.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 85%
filed 2026-10-22
The 6-K discloses two capital-raising transactions: (1) an at-the-market (ATM) offering of up to $50 million in Class A Ordinary Shares entered into on October 22, 2026, and (2) a closed notes offering from September 10, 2026, involving $850,000 in convertible promissory notes plus 100,000 commitment shares. Both transactions involve dilutive equity issuances to raise capital. The ATM agreement with Chaince Securities and the convertible notes with institutional investors are material financing events that would affect a reasonable investor's assessment of the registrant's capital structure and dilution.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-10-22
Item 1.01
Valor Energy Inc. entered into a definitive agreement to acquire 100% of the equity interests of Glorious Star LLC for $3.6 million, which holds interests in a computing center project in Youngstown, Ohio. This is a material acquisition of a target company and its assets, disclosed under Item 1.01 (Entry into a Material Definitive Agreement), and would materially affect a reasonable investor's assessment of the registrant's capital deployment and strategic direction.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-10-22
The 6-K discloses shareholder approval of a material acquisition: Critical Metals Corp.'s proposed acquisition of European Lithium by way of two schemes of arrangement under Australian law. On October 22, 2026, European Lithium shareholders and optionholders voted overwhelmingly in favor (99.96% and 100% respectively), satisfying securityholder approval conditions. The transaction remains subject to court approval scheduled for October 26, 2026, with implementation expected November 5, 2026. This is a material acquisition event requiring disclosure under Item 1.01 or 2.01 equivalent.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-22
Item 5.02
The filing discloses the appointment of Robert Wong as Vice President, Chief Accounting Officer (Principal Accounting Officer) of Retension Pharmaceuticals, effective November 2, 2026. The principal disclosed action is a person taking a role—a key executive position responsible for accounting and financial reporting. While the filing also includes compensatory details (base salary, bonus, sign-on bonus, and stock options), the core event is the appointment itself, making this an exec_appointment rather than exec_compensation.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-10-22
Item 1.01
The filing discloses an Amendment to a Business Combination Agreement dated October 22, 2026, between Inflection Point Acquisition Corp. VI, its subsidiaries, and Quantum Space, LLC. The Amendment modifies material terms of the previously disclosed June 8, 2026 Business Combination Agreement, including changing the listing venue from Nasdaq to NYSE and modifying post-Closing board composition requirements. This constitutes a material amendment to an existing definitive agreement for a business combination, which is a core M&A activity event under Item 1.01.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-10-22
EX-99.1
This news release announces Ballard's strategic business model expansion and financial targets disclosed at the Ballard Forum, including a shift to Energy-as-a-Service, 30% revenue CAGR targets, gross margin expansion to 20%+ by 2027 and 25%+ by 2028, and a path to adjusted EBITDA profitability by end of 2027. While the release contains forward-looking guidance rather than reported results, it discloses material strategic and operational initiatives (expanded business model, fleet expansion with $80–120M capex, and profitability targets) that would affect a reasonable investor's assessment of the company's direction and financial prospects.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-10-22
EX-99.1
This news release announces the filing of an independent NI 43-101 technical report supporting a maiden Mineral Resource estimate for the Apollo deposit at the Guayabales Project in Colombia. The disclosure details a significant exploration milestone—a 2.58 million ounce AuEq Indicated resource and 2.83 million ounce AuEq Inferred resource—which is material to investors' assessment of the company's asset base and development potential. While not a discrete operational event like a contract or partnership, this represents a material advancement of the company's flagship mineral property that would affect a reasonable investor's valuation of the exploration company.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-10-22
Item 7.01
The disclosure announces a material operational milestone: completion of first product deliveries by affiliate SEA Craft to Illinois dispensaries following facility restart in June 2026, with initial 5,000 sq ft flowering canopy and planned expansion to 10,000 sq ft. This represents a significant market entry and operational achievement for the company's Illinois operations, but does not fit the specific categories of earnings release, M&A activity, or other named event types. The operational nature and materiality to investors assessing the company's growth trajectory and market expansion justify classification as operational_other.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-10-22
Item 2.02
MaxLinear issued a press release on October 22, 2026 announcing unaudited financial results for Q3 2026 ended September 30, 2026, with net revenue of $218.1 million (up 72% year-over-year), diluted EPS of $0.30 GAAP and $0.62 non-GAAP.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-10-22
Item 1.01
MaxLinear entered into Amendment No. 3 to its Credit Agreement on October 16, 2026, increasing revolving credit commitments by $70 million to a total of $200 million, materially expanding the company's available liquidity under its senior secured revolving credit facility.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-10-22
EX-99.1
The exhibit announces the Board of Directors' appointment of Armando José Cuello Navarro as Executive Vice President of Energy Transition, effective no later than October 27, 2026, as part of Ecopetrol's "New Era" strategy to strengthen senior management. The disclosure also includes appointments of two legal representatives (Camilo Andrés Rojas Castro and Mauricio Gutiérrez Dangond). The appointment of a senior executive officer to a newly created or restructured C-suite position is a material governance event affecting the registrant's leadership structure.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 75%
filed 2026-10-22
The filing discloses a share buyback program authorized by the Board of Directors under CVM Instruction No. 80/2022. The stated objective is to acquire up to 106.6 million shares (common and preferred) from "Profit Reserves – Statutory" for treasury, with the economic effect being "greater financial return due to the proportional increase in the amount of dividends/interest on shareholder's equity distributed per share." This is a capital allocation decision designed to enhance per-share dividend returns to remaining shareholders, which is material to investors assessing shareholder value and capital deployment strategy.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-10-22
Item 2.03
The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Des Moines. Schedule A lists multiple debt securities with trade dates of 10/19/2026 and 10/20/2026, including variable-rate floaters and fixed-rate bonds totaling approximately $2.797 billion in principal. The Bank explicitly states that "consolidated obligations issuance is material to the Bank," and Item 2.03 is the designated disclosure item for creation of direct financial obligations, making this a clear debt issuance event.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-10-22
Item 2.03
The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds by the Federal Home Loan Bank of Topeka. Schedule A reports two debt securities issued on trade dates 10/19/2026 and 10/20/2026, totaling $15 million in principal, with maturities in 2030. This is a classic debt issuance under Item 2.03, creating new direct financial obligations in the capital markets.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-10-22
Item 2.03
The FHLB Cincinnati filed Item 2.03 disclosing the issuance of multiple Consolidated Bonds (debt securities) totaling approximately $5.644 billion across ten tranches with trade dates of October 19-20, 2026. The filing explicitly states that "Consolidated Obligations issuance is material to the FHLB," and Schedule A details the principal amounts, maturity dates, and terms of each bond issuance, which constitutes creation of direct financial obligations under Item 2.03.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-10-22
Item 2.02
Federal Home Loan Bank of Pittsburgh disclosed quarterly and nine-month financial results for the period ended September 30, 2026, reporting net income of $134.7 million for Q3 and $326.4 million year-to-date, along with dividend declarations on membership and activity stock.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-10-22
Item 2.03
The filing discloses the creation of multiple direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Pittsburgh. Schedule A details 16 separate debt issuances with trade dates of 10/19/2026 and 10/20/2026, totaling approximately $10.5 billion in principal amount across various maturities and rate structures. The Item 2.03 heading and the explicit statement that "consolidated obligations issuance is material to the FHLBank" confirm this is a debt issuance event.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-10-22
Item 2.03
The filing discloses the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Chicago on trade dates of October 19–20, 2026, with principal amounts totaling approximately $1.015 billion across five securities (ranging from $150 million to $500 million). Schedule A itemizes each issuance with CUSIP, settlement date, maturity date, rate type, and coupon. This is a classic debt_issuance event under Item 2.03, creating direct financial obligations through the sale of debt securities in the capital markets.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-10-22
Item 2.03
The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Boston. Schedule A details seven specific debt issuances with trade dates in October 2026, totaling approximately $624.5 million in principal, with maturities ranging from 2027 to 2029. This is a classic debt_issuance event under Item 2.03, representing new direct financial obligations created by the registrant.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-10-22
Item 2.02
Federal Home Loan Bank of Atlanta disclosed preliminary unaudited financial results for Q3 2026 via press release, reporting net income of $126 million, net interest income of $183 million, and ROE of 5.71%.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-10-22
Item 8.01
The board of directors declared a quarterly cash dividend at an annualized rate of 6.20 percent, with payment credited to members' capital stock accounts on October 27, 2026.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-10-22
Item 2.03
The filing discloses the issuance of a consolidated obligation bond with a principal amount of $500,000,000, traded on 10/20/2026 and settling on 10/22/2026, maturing 1/22/2027. This represents a direct financial obligation created by the Bank through the sale of debt securities in the capital markets, which is the core purpose of Item 2.03 disclosure. The materiality is evident from the substantial principal amount and the Bank's explicit statement that "consolidated obligations issuance is material to the Bank."
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-10-22
Item 2.03
The filing discloses the Federal Home Loan Bank of Indianapolis becoming the primary obligor on consolidated obligation bonds with a total par value of $380 million across six separate bond issuances with maturities ranging from 2028 to 2038. This constitutes creation of direct financial obligations under Item 2.03, which is the core definition of debt issuance. The bonds carry fixed and variable coupon rates and settlement dates in October and November 2026.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-10-22
Item 2.03
The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds totaling approximately $4.825 billion across eight separate bond offerings with trade dates of October 19-20, 2026. Schedule A details the specific bonds committed to be issued, including CUSIP numbers, settlement dates, maturity dates, and coupon rates (variable SOFR-based rates). This is a classic debt issuance under Item 2.03, representing new direct financial obligations of the Federal Home Loan Bank of Dallas.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-10-22
Item 8.01
The disclosure centers on Mueller Water Products' Board declaration of a quarterly cash dividend of $0.080 per share, representing a 14.3% increase from the prior $0.070 per share, payable November 19, 2026. While the filing also announces a $300 million share repurchase authorization expansion, the primary event disclosed under Item 8.01 is the dividend increase, which is a material return of capital to shareholders that would affect investor assessment of the company's capital allocation strategy and financial position.
View raw filing on EDGAR →